References

References: Science in Detail 7 · The Machinery, Named One Part at a Time

  1. Doumouchtsis KK, Doumouchtsis SK, Doumouchtsis EK, Perrea DN. The effect of lead intoxication on endocrine functions. J Endocrinol Invest. 2009;32(2):175-183.
  2. Iavicoli I, Fontana L, Bergamaschi A. The effects of metals as endocrine disruptors. J Toxicol Environ Health B Crit Rev. 2009;12(3):206-223.
  3. Telisman S, Cvitković P, Jurasović J, Pizent A, Gavella M, Rocić B. Semen quality and reproductive endocrine function in relation to biomarkers of lead, cadmium, zinc, and copper in men. Environ Health Perspect. 2000;108(1):45-53.
  4. Iavicoli I, Fontana L, Bergamaschi A, 'The effects of metals as endocrine disruptors', Journal of Toxicology and Environmental Health Part B 12(3):206-223, 2009
  5. Rana SVS, 'Perspectives in endocrine toxicity of heavy metals — a review', Biological Trace Element Research 160:1-14, 2014
  6. Walker WH, 'Testosterone signaling and the regulation of spermatogenesis,' Spermatogenesis 1(2):116-120, 2011.
  7. Sharpe RM, 'Sperm counts and fertility in men: a rocky road ahead,' EMBO Reports 13(5):398-403, 2012.
  8. Konkle ATM, McCarthy MM. Developmental Time Course of Estradiol, Testosterone, and Dihydrotestosterone Levels in Discrete Regions of Male and Female Rat Brain. Endocrinology. 2011;152(1):223-235.
  9. Lenz KM, Nugent BM, McCarthy MM. Sexual differentiation of the rodent brain: dogma and beyond. Front Neurosci. 2012;6:26.
  10. Sokol RZ. (1987). Hormonal effects of lead acetate in the male rat: mechanism of action. Biology of Reproduction, 37(5), 1135-1138.
  11. Doumouchtsis KK, Doumouchtsis SK, Doumouchtsis EK, Perrea DN. (2009). The effect of lead intoxication on endocrine functions. Journal of Endocrinological Investigation, 32(2), 175-183.
  12. Vannier B, Raynaud JP. Effect of estrogen plasma binding on sexual differentiation of the rat fetus. Molecular and Cellular Endocrinology 3(5):323-337, 1975.
  13. Toran-Allerand CD. On the genesis of sexual differentiation of the central nervous system: morphogenetic consequences of steroidal exposure and possible role of alpha-fetoprotein. Progress in Brain Research 61:63-98, 1984.
  14. Skakkebaek NE, et al. Male reproductive disorders and fertility trends. Physiol Rev. 2016;96(1):55-97. PMID 26582516.
  15. Sharpe RM, Skakkebaek NE. Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects. Fertil Steril. 2008;89(2 Suppl):e33-e38. PMID 18308057.
  16. McCarthy MM, 'Estradiol and the developing brain,' Physiol Rev 88(1):91-124, 2008.
  17. MacLusky NJ & Naftolin F, 'Sexual differentiation of the central nervous system,' Science 211(4488):1294-1302, 1981.
  18. Wilhelm D, Palmer S, Koopman P. Sex determination and gonadal development in mammals. Physiol Rev. 2007;87(1):1-28.
  19. Eggers S, Sinclair A. Mammalian sex determination — insights from humans and mice. Chromosome Res. 2012;20(1):215-238.
  20. Capel B. Vertebrate sex determination: evolutionary plasticity of a fundamental switch. Nat Rev Genet. 2017;18(11):675-689.
  21. Moore KL, Persaud TVN, Torchia MG. The Developing Human: Clinically Oriented Embryology, 11th ed. Elsevier (2019).
  22. Welsh M, Saunders PTK, Fisken M, et al. "Identification in rats of a programming window for reproductive tract masculinization." J. Clin. Invest. 118(4):1479–1490 (2008).
  23. Vandenberg LN et al. 'Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses.' Endocrine Reviews 33(3):378-455, 2012.
  24. Gore AC et al. 'EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals.' Endocrine Reviews 36(6):E1-E150, 2015.
  25. Hughes IA et al., Arch Dis Child 91(7):554-563, 2006.
  26. Mongan NP et al., Best Pract Res Clin Endocrinol Metab 29(4):569-580, 2015.
  27. Wilson JD, George FW, Griffin JE, Science 211(4488):1278-1284, 1981.
  28. Rey R & Grinspon RP, Best Pract Res Clin Endocrinol Metab 25(2):221-238, 2011.
  29. Moore KL & Persaud TVN, The Developing Human, 10th ed., Elsevier, 2016.
  30. Yamada G et al., 'Molecular genetic cascades for external genitalia formation,' Differentiation 71(8):445-460, 2003.
  31. Wilson JD, Griffin JE, Russell DW, 'Steroid 5alpha-reductase 2 deficiency,' Endocr Rev 14(5):577-593, 1993.
  32. White PC & Speiser PW, 'Congenital adrenal hyperplasia due to 21-hydroxylase deficiency,' Endocr Rev 21(3):245-291, 2000.
  33. Speiser PW et al., J Clin Endocrinol Metab 95(9):4133-4160, 2010.
  34. Imperato-McGinley J, Guerrero L, Gautier T, Peterson RE. Steroid 5alpha-reductase deficiency in man. Science. 1974;186(4170):1213-1215.
  35. Imperato-McGinley J, Peterson RE, Gautier T, Sturla E. Androgens and the evolution of male-gender identity among male pseudohermaphrodites with 5alpha-reductase deficiency. N Engl J Med. 1979;300(22):1233-1237.
  36. Imperato-McGinley J, Peterson RE, Gautier T, Sturla E. NEJM. 1979;300(22):1233-1237.
  37. Maimoun L, et al. J Clin Endocrinol Metab. 2011;96(2):296-307.
  38. Mendonca BB, Gomes NL, Costa EMF, et al. 46,XY disorder of sex development (DSD) due to 17beta-hydroxysteroid dehydrogenase type 3 deficiency. J Steroid Biochem Mol Biol. 2017;165(Pt A):79-85.
  39. Vandenberg LN et al., 'Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses,' Endocr Rev 33(3):378-455, 2012.
  40. Gore AC et al., 'EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals,' Endocr Rev 36(6):E1-E150, 2015.
  41. Grino PB, Griffin JE, Wilson JD, 'Testosterone at high concentrations interacts with the human androgen receptor similarly to dihydrotestosterone,' Endocrinology 126(2):1165-1172, 1990.
  42. Imperato-McGinley J & Zhu YS, '5alpha-reductase-2 deficiency and complete androgen insensitivity,' Baillieres Clin Endocrinol Metab 12(1):395-432, 1998.
  43. Thornton JW. 'Evolution of vertebrate steroid receptors from an ancestral estrogen receptor by ligand exploitation and serial genome expansions.' PNAS 98(10):5671-5676, 2001.
  44. Eick GN, Thornton JW. 'Evolution of steroid receptors from an ancestral estrogen receptor by ligand exploitation and serial genome expansions.' Molecular and Cellular Endocrinology 334(1-2):31-38, 2011.
  45. Vandenberg LN et al., Endocrine Reviews 33(3):378-455, 2012.
  46. Gore AC et al., Endocrine Reviews 36(6):E1-E150, 2015.
  47. Vandenberg LN, Colborn T, Hayes TB, et al. 'Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses.' Endocrine Reviews 33(3):378-455, 2012.
  48. Diamanti-Kandarakis E, Bourguignon J-P, Giudice LC, et al. 'Endocrine-disrupting chemicals: an Endocrine Society scientific statement.' Endocrine Reviews 30(4):293-342, 2009.
  49. Gray LE Jr, Ostby J, Monosson E, Kelce WR. Toxicology and Industrial Health 15(1-2):48-64, 1999.
  50. Wilson JD et al. Endocrine Reviews 2(1):104-122, 1981.
  51. Thornton JW. PNAS 98(10):5671-5676, 2001.
  52. Norris DO, Carr JA. Vertebrate Endocrinology, 5th ed. Academic Press, 2013.
  53. Wetherill YB, Akingbemi BT, Kanno J, et al. In vitro molecular mechanisms of bisphenol A action. Reprod Toxicol 24(2):178-198, 2007.
  54. Gore AC, et al. EDC-2: The Endocrine Society's Second Scientific Statement. Endocr Rev 36(6):E1-E150, 2015.
  55. Bridgham JT, Carroll SM, Thornton JW. Evolution of hormone-receptor complexity by molecular exploitation. Science 312(5770):97-101 (2006).
  56. Diamanti-Kandarakis E et al. "Endocrine-disrupting chemicals: an Endocrine Society scientific statement." Endocrine Reviews 30(4):293-342 (2009).
  57. Gore AC et al. "EDC-2: The Endocrine Society's Second Scientific Statement." Endocrine Reviews 36(6):E1-E150 (2015).
  58. Baker ME. 'Steroid receptor phylogeny and vertebrate origins.' Molecular and Cellular Endocrinology 135(2):101-107, 1997.
  59. The Endocrine Disruption Exchange (TEDX). TEDX List of Potential Endocrine Disruptors.
  60. Gore AC, Chappell VA, Fenton SE, et al. EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals. Endocr Rev 36(6):E1-E150, 2015.
  61. Krishnan AV et al. (1993). Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology, 132(6), 2279-2286.
  62. Welshons WV et al. (2006). Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology, 147(6 Suppl), S56-S69.
  63. Eick GN, Thornton JW. Evolution of steroid receptors from an estrogen-sensitive ancestral receptor. Molecular and Cellular Endocrinology 334(1-2):31-38, 2011.
  64. Kelley DB. Sexually dimorphic behaviors. Annual Review of Neuroscience 11:225-251, 1988.
  65. Hayes TB et al. Demasculinization and feminization of male gonads by atrazine: consistent effects across vertebrate classes. Journal of Steroid Biochemistry and Molecular Biology 127(1-2):64-73, 2011.
  66. Diamanti-Kandarakis E, et al. (2009). Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocrine Reviews, 30(4), 293-342.
  67. Gore AC, et al. (2015). EDC-2. Endocrine Reviews, 36(6), E1-E150.
  68. Kuiper GG, Lemmen JG, Carlsson B, et al. (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology, 139(10), 4252-4263.
  69. Vandenberg LN, Colborn T, Hayes TB, et al. (2012). Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocrine Reviews, 33(3), 378-455.
  70. Nishikawa J, et al. Involvement of the retinoid X receptor in the development of imposex caused by organotins in gastropods. Environ Sci Technol. 2004;38(23):6271-6276.
  71. Castro LFC, Lima D, et al. Imposex induction is mediated through the retinoid X receptor signalling pathway in the neogastropod Nucella lapillus. Aquat Toxicol. 2007;85(1):57-66.
  72. Gore AC, Chappell VA, Fenton SE, et al. "EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals." Endocrine Reviews 36(6):E1-E150, 2015.
  73. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, et al. "Endocrine-disrupting chemicals: an Endocrine Society scientific statement." Endocrine Reviews 30(4):293-342, 2009.
  74. Thornton JW, Need E, Crews D. "Resurrecting the ancestral steroid receptor: ancient origin of estrogen signaling." Science 301(5640):1714-1717, 2003.
  75. Fan W, et al. 'Atrazine-induced aromatase expression is SF-1 dependent: implications for endocrine disruption in wildlife and reproductive cancers in humans.' Environ Health Perspect 115(5):720-727 (2007).
  76. Hayes TB, et al. PNAS 107(10):4612-4617 (2010) and refs therein on aromatase activity in male X. laevis.
  77. Bhasin S et al., 'Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men,' J Clin Endocrinol Metab 96(8):2430-2439, 2011.
  78. Mooradian AD, Morley JE, Korenman SG, 'Biological actions of androgens,' Endocr Rev 8(1):1-28, 1987.
  79. Kuiper GG, Carlsson B, Grandien K, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138(3):863-870, 1997.
  80. Korach KS. Diethylstilbestrol metabolites and analogs: new probes for the study of hormone action. J Biol Chem 254(18):8963-8968, 1979.
  81. Zoeller RT & Rovet J. (2004). Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings. Journal of Neuroendocrinology, 16(10), 809-818.
  82. Bernal J. (2007). Thyroid hormone receptors in brain development and function. Nature Clinical Practice Endocrinology & Metabolism, 3(3), 249-259.
  83. Phoenix CH, Goy RW, Gerall AA, Young WC. "Organizing action of prenatally administered testosterone propionate on the tissues mediating mating behavior in the female guinea pig." Endocrinology 65:369-382 (1959).
  84. Arnold AP. "The organizational-activational hypothesis as the foundation for a unified theory of sexual differentiation of all mammalian tissues." Hormones and Behavior 55(5):570-578 (2009).
  85. McCarthy MM, Arnold AP. "Reframing sexual differentiation of the brain." Nature Neuroscience 14(6):677-683 (2011).
  86. Pool KR, et al. Ancestral lineages of dietary exposure to an endocrine disrupting chemical drive distinct forms of transgenerational subfertility in an insect model. Scientific Reports 14, 2024 (PMID 39103404).
  87. Heard E, Martienssen RA. Transgenerational epigenetic inheritance: myths and mechanisms. Cell 157(1):95-109, 2014.
  88. Protostome–deuterostome divergence ~500–600 Mya (deep bilaterian animal split).
  89. Jones PA, Functions of DNA methylation: islands, start sites, gene bodies and beyond, Nat Rev Genet 13(7):484-492, 2012
  90. Moore LD, Le T, Fan G, DNA methylation and its basic function, Neuropsychopharmacology 38(1):23-38, 2013
  91. US Surgeon General. The Health Consequences of Smoking — 50 Years of Progress. CDC, 2014.
  92. NIEHS. Lead and Your Health.
  93. Mossman BT, Churg A. Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med. 1998;157(5):1666-1680.
  94. Plant TM. 60 Years of neuroendocrinology: The hypothalamo-pituitary-gonadal axis. J Endocrinol. 2015;226(2):T41-T54. PMID 25901041.
  95. Markowitz G, Rosner D. (2002). Deceit and Denial: The Deadly Politics of Industrial Pollution. University of California Press.
  96. Michaels D. (2020). The Triumph of Doubt: Dark Money and the Science of Deception. Oxford University Press.
  97. Oreskes N & Conway EM, 'Merchants of Doubt: How a Handful of Scientists Obscured the Truth on Issues from Tobacco Smoke to Global Warming,' Bloomsbury Press, 2010.
  98. Markowitz G & Rosner D, 'Deceit and Denial: The Deadly Politics of Industrial Pollution,' University of California Press / Milbank, 2002.
  99. European Commission. Chemicals Strategy for Sustainability — Towards a Toxic-Free Environment (COM(2020) 667 final).
  100. European Chemicals Agency (ECHA). Endocrine disruptors — regulatory criteria and identification under REACH, biocides, and plant-protection regulations.
  101. Bergman A, Heindel JJ, Jobling S, Kidd KA, Zoeller RT (eds.). (2013). State of the Science of Endocrine Disrupting Chemicals - 2012. WHO/UNEP.
  102. Gore AC, et al. (2015). EDC-2: The Endocrine Society's Second Scientific Statement. Endocrine Reviews, 36(6), E1-E150.